Payment Breakdown by Category
Payments by Nature
| Nature of Payment | Amount | Transactions | Share |
|---|---|---|---|
| Food and Beverage | $1,226 | 87 | 100.0% |
Top Paying Companies
| Company | Total | Records | Latest Year |
|---|---|---|---|
| Novo Nordisk Inc | $140.07 | 10 | $0 (2018) |
| SANOFI-AVENTIS U.S. LLC | $137.29 | 9 | $0 (2018) |
| AstraZeneca Pharmaceuticals LP | $136.21 | 10 | $0 (2019) |
| PFIZER INC. | $131.55 | 13 | $0 (2018) |
| Lilly USA, LLC | $108.82 | 8 | $0 (2019) |
| Indivior Inc. | $86.67 | 5 | $0 (2024) |
| GlaxoSmithKline, LLC. | $75.60 | 5 | $0 (2017) |
| Boehringer Ingelheim Pharmaceuticals, Inc. | $68.95 | 4 | $0 (2019) |
| Purdue Pharma L.P. | $63.78 | 4 | $0 (2018) |
| Otsuka America Pharmaceutical, Inc. | $62.05 | 4 | $0 (2020) |
Payment History by Year
| Year | Amount | Transactions | Top Company |
|---|---|---|---|
| 2024 | $49.27 | 3 | Braeburn Inc. ($30.00) |
| 2022 | $44.59 | 3 | Indivior Inc. ($44.59) |
| 2020 | $60.40 | 4 | Otsuka America Pharmaceutical, Inc. ($24.02) |
| 2019 | $155.91 | 10 | Otsuka America Pharmaceutical, Inc. ($38.03) |
| 2018 | $442.52 | 35 | PFIZER INC. ($121.13) |
| 2017 | $473.69 | 32 | GlaxoSmithKline, LLC. ($75.60) |
All Payment Transactions
87 individual payment records from CMS Open Payments — Page 1 of 4
| Date | Company | Product | Nature | Form | Amount | Type |
|---|---|---|---|---|---|---|
| 11/06/2024 | Indivior Inc. | SUBLOCADE (Drug) | Food and Beverage | In-kind items and services | $19.27 | General |
| Category: OUD | ||||||
| 08/29/2024 | Braeburn Inc. | BRIXADI (Drug) | Food and Beverage | In-kind items and services | $16.79 | General |
| Category: Opioid Use Disorder | ||||||
| 04/25/2024 | Braeburn Inc. | BRIXADI (Drug) | Food and Beverage | In-kind items and services | $13.21 | General |
| Category: Opioid Use Disorder | ||||||
| 03/17/2022 | Indivior Inc. | SUBLOCADE (Drug) | Food and Beverage | In-kind items and services | $11.75 | General |
| Category: OUD | ||||||
| 01/30/2022 | Indivior Inc. | SUBLOCADE (Drug) | Food and Beverage | In-kind items and services | $12.06 | General |
| Category: OUD | ||||||
| 01/05/2022 | Indivior Inc. | SUBLOCADE (Drug) | Food and Beverage | In-kind items and services | $20.78 | General |
| Category: OUD | ||||||
| 10/09/2020 | Otsuka America Pharmaceutical, Inc. | REXULTI (Drug) | Food and Beverage | In-kind items and services | $11.56 | General |
| Category: PSYCHIATRY | ||||||
| 08/24/2020 | Neuronetics, Inc. | NEUROSTAR TMS THERAPY (Device) | Food and Beverage | In-kind items and services | $13.57 | General |
| Category: NEUROSTAR TMS THERAPY | ||||||
| 06/26/2020 | Otsuka America Pharmaceutical, Inc. | REXULTI (Drug) | Food and Beverage | In-kind items and services | $12.46 | General |
| Category: PSYCHIATRY | ||||||
| 01/17/2020 | Indivior Inc. | SUBLOCADE (Drug) | Food and Beverage | In-kind items and services | $22.81 | General |
| Category: OUD | ||||||
| 12/04/2019 | Janssen Pharmaceuticals, Inc | XARELTO (Drug), INVOKANA | Food and Beverage | In-kind items and services | $12.35 | General |
| Category: Cardiovascular & Metabolism | ||||||
| 10/18/2019 | Otsuka America Pharmaceutical, Inc. | REXULTI (Drug) | Food and Beverage | In-kind items and services | $17.54 | General |
| Category: PSYCHIATRY | ||||||
| 10/02/2019 | Janssen Pharmaceuticals, Inc | INVOKANA (Drug) | Food and Beverage | In-kind items and services | $13.49 | General |
| Category: Cardiovascular & Metabolism | ||||||
| 09/27/2019 | Otsuka America Pharmaceutical, Inc. | ABILIFY MAINTENA (Drug) | Food and Beverage | In-kind items and services | $20.49 | General |
| Category: PSYCHIATRY | ||||||
| 09/23/2019 | Astellas Pharma US Inc | MYRBETRIQ (Drug) | Food and Beverage | In-kind items and services | $13.32 | General |
| Category: UROLOGY | ||||||
| 05/22/2019 | Boehringer Ingelheim Pharmaceuticals, Inc. | — | Food and Beverage | In-kind items and services | $20.33 | General |
| 04/17/2019 | Lilly USA, LLC | TRULICITY (Drug), JARDIANCE, BASAGLAR | Food and Beverage | In-kind items and services | $14.72 | General |
| Category: Diabetes | ||||||
| 02/14/2019 | Melinta Therapeutics, Inc. | Baxdela (Drug) | Food and Beverage | In-kind items and services | $15.22 | General |
| Category: ANTIBIOTICS | ||||||
| 02/13/2019 | Lilly USA, LLC | TRULICITY (Drug), JARDIANCE, BASAGLAR | Food and Beverage | In-kind items and services | $13.41 | General |
| Category: Diabetes | ||||||
| 01/07/2019 | AstraZeneca Pharmaceuticals LP | FARXIGA (Drug) | Food and Beverage | In-kind items and services | $15.04 | General |
| Category: Cardiovascular and Metabolism | ||||||
| 11/26/2018 | PFIZER INC. | LYRICA (Drug), EUCRISA, COLOGUARD | Food and Beverage | In-kind items and services | $13.93 | General |
| Category: NEUROSCIENCE;PAIN | ||||||
| 10/15/2018 | Lilly USA, LLC | TRULICITY (Drug), JARDIANCE, BASAGLAR | Food and Beverage | In-kind items and services | $11.53 | General |
| Category: Diabetes | ||||||
| 10/10/2018 | PFIZER INC. | CHANTIX (Drug), ELIQUIS | Food and Beverage | In-kind items and services | $12.74 | General |
| Category: NEUROSCIENCE;TOBACCO DEPENDENCE | ||||||
| 10/10/2018 | PFIZER INC. | CHANTIX (Drug), ELIQUIS | Food and Beverage | In-kind items and services | $0.66 | General |
| Category: NEUROSCIENCE;TOBACCO DEPENDENCE | ||||||
| 10/08/2018 | PFIZER INC. | LYRICA (Drug), EUCRISA, COLOGUARD | Food and Beverage | In-kind items and services | $9.61 | General |
| Category: NEUROSCIENCE;PAIN | ||||||
Medicare Billing by Year
| Year | Procedures | Beneficiaries | Services | Submitted | Medicare Paid |
|---|---|---|---|---|---|
| 2023 | 2 | 39 | 79 | $17,579 | $3,668 |
| 2022 | 2 | 78 | 206 | $42,214 | $9,676 |
| 2021 | 2 | 66 | 165 | $33,006 | $8,268 |
| 2020 | 4 | 99 | 337 | $55,158 | $21,176 |
All Medicare Procedures & Services
10 procedure records from CMS Medicare Utilization
| HCPCS | Description | Setting | Year | Patients | Services | Charges | Medicare Paid | Ratio |
|---|---|---|---|---|---|---|---|---|
| 11042 | Removal of skin and tissue, 20.0 sq cm or less | Facility | 2023 | 25 | 64 | $13,952 | $2,908 | 20.8% |
| 99213 | Established patient office or other outpatient visit, 20-29 minutes | Facility | 2023 | 14 | 15 | $3,627 | $760.65 | 21.0% |
| 11042 | Removal of skin and tissue, 20.0 sq cm or less | Facility | 2022 | 53 | 176 | $38,368 | $8,128 | 21.2% |
| 99213 | Established patient office or other outpatient visit, 20-29 minutes | Facility | 2022 | 25 | 30 | $3,846 | $1,548 | 40.2% |
| 11042 | Removal of skin and tissue first 20 sq cm or less | Facility | 2021 | 43 | 127 | $27,686 | $5,960 | 21.5% |
| 99214 | Established patient outpatient visit, total time 30-39 minutes | Office | 2021 | 23 | 38 | $5,320 | $2,308 | 43.4% |
| 99214 | Established patient office or other outpatient, visit typically 25 minutes | Office | 2020 | 35 | 199 | $27,860 | $15,314 | 55.0% |
| 11042 | Removal of skin and tissue first 20 sq cm or less | Facility | 2020 | 36 | 100 | $21,800 | $4,719 | 21.6% |
| 99203 | New patient office or other outpatient visit, typically 30 minutes | Office | 2020 | 12 | 12 | $1,884 | $816.18 | 43.3% |
| 80305 | Testing for presence of drug | Office | 2020 | 16 | 26 | $3,614 | $326.10 | 9.0% |
About Dr. Dan Criswell, MD
Dr. Dan Criswell, MD is a Family Medicine healthcare provider based in Duncan, Oklahoma. This provider has been registered with the National Plan and Provider Enumeration System (NPPES) since 06/07/2006. The National Provider Identifier (NPI) number assigned to this provider is 1043250103.
According to the Centers for Medicare & Medicaid Services (CMS) Open Payments database, Dr. Dan Criswell, MD has received a total of $1,226 in payments from pharmaceutical and medical device companies, with $49.27 received in 2024. These payments were reported across 87 transactions from 19 companies. The most common payment nature is "Food and Beverage" ($1,226).
As a Medicare-enrolled provider, Criswell has provided services to 282 Medicare beneficiaries, totaling 787 services with total Medicare billing of $42,788. Data is available for 4 years (2020–2023), covering 10 distinct procedure/service records.
Practice Information
- Specialty Family Medicine
- Other Specialties Addiction Medicine
- Location Duncan, OK
- Active Since 06/07/2006
- Last Updated 12/09/2019
- Taxonomy Code 207Q00000X
- Entity Type Individual
- NPI Number 1043250103
Products in Payments
- FARXIGA (Drug) $136.21
- TOUJEO (Drug) $125.59
- SUBLOCADE (Drug) $86.67
- TRULICITY (Drug) $84.73
- CHANTIX (Drug) $68.14
- LYRICA (Drug) $52.99
- BREO (Drug) $47.40
- REXULTI (Drug) $41.56
- TRADJENTA (Drug) $36.79
- Ozempic (Drug) $31.46
- BRIXADI (Drug) $30.00
- MYRBETRIQ (Drug) $27.73
- XARELTO (Drug) $26.59
- STIOLTO (Drug) $23.16
- JANUVIA (Drug) $22.88
- Movantik (Drug) $21.26
- ABILIFY MAINTENA (Drug) $20.49
- HYSINGLA ER (Drug) $19.20
- BELSOMRA (Drug) $17.85
- ANORO (Drug) $17.81
Explore
Data Sources
Provider data from NPPES. Payment data from CMS Open Payments. Medicare data from CMS Medicare Provider Utilization. All data is public and updated periodically.
Family Medicine Doctors in Duncan
Mr. Michael Tanbonliong, Md, MD
Family Medicine — Payments: $15,207
Francis Mcgouran, M.d, M.D
Family Medicine — Payments: $8,447
Melissa Hurst, Md, MD
Family Medicine — Payments: $3,821
Krystal Vonfeldt, Do, DO
Family Medicine — Payments: $3,584
Antoinette Rhynes, Md, MD
Family Medicine — Payments: $3,317
Walter Kucaba, Do, DO
Family Medicine — Payments: $3,263